You are in the accessibility menu

Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKalva Borato, Danielle Cristyane-
dc.contributor.authorParabocz, Gisele Chibinski-
dc.contributor.authorWeber Ribas, Sonia Regina-
dc.contributor.authorKalva-Filho, Carlos Augusto-
dc.contributor.authorBorba, Luciana Maria-
dc.contributor.authorSanches Ito, Carmen Antonia-
dc.contributor.authorBail, Larissa-
dc.contributor.authordos Santos, Fabio Andre-
dc.contributor.authorRebuglio Vellosa, Jose Carlos-
dc.identifier.citationMetabolism-clinical and Experimental. Philadelphia: W B Saunders Co-elsevier Inc, v. 61, n. 10, p. 1353-1360, 2012.-
dc.description.abstractObjective: HIV infection is exacerbated through additional pro-atherogenic mechanisms related to the processes of immune activation, inflammation, coagulation, and the modification of lipoproteins (e.g., particles of high density lipoprotein), contributing to increased cardiovascular risk. The aim of this study was to analyze the serum concentrations of myeloperoxidase (MPO) and other laboratory parameters in HIV-infected patients treated or not with antiretroviral drugs compared to non-infected individuals.Materials/Methods: The study included 154 volunteers: 47 non-infected individuals (control group - CON), 27 infected and untreated individuals (NTARv group) and 80 treated individuals (TARV group). We analyzed the counts of CD4+ lymphocytes and the viral load of the infected patients, along with the blood count, fasting glucose, total serum cholesterol (CHOL), HDL cholesterol, LDL cholesterol, triglycerides, MPO and high-sensitivity C-reactive protein (CRP) of all study participants.Results: There were significant increases in glucose, CHOL, LDL cholesterol, and triglycerides in the TARV group and significant reductions in the levels of HDL cholesterol for the TARV and NTARV groups. Significantly elevated levels of Hs-CRP were observed only in the TARV group, while levels of MPO were significantly higher in the TARV and NTARV groups compared to the control group. A correlation of MPO with Hs-CRP (r = 0.21, p = 0.032) was observed for HIV-infected patients, but MPO did not correlate significantly with the other analyzed parameters.Conclusions: The investigation of early biomarkers for cardiovascular risk evaluation, such as MPO, contributes to the clinical monitoring of HIV-infected individuals. The serum levels of MPO correlated with Hs-CRP and were high in HIV-infected individuals, indicating a possible predictor of cardiovascular events in these patients. (c) 2012 Elsevier B.V. All rights reserved.en
dc.description.sponsorshipFundação Araucária de Apoio ao Desenvolvimento Científico e Tecnológico do Paraná (FAADCT/PR)-
dc.publisherW B Saunders Co-elsevier Inc-
dc.sourceWeb of Science-
dc.titleChanges of metabolic and inflammatory markers in HIV infection: glucose, lipids, serum Hs-CRP and myeloperoxidaseen
dc.contributor.institutionUniversidade Estadual de Ponta Grossa (UEPG)-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.description.affiliationParana State Univ Ponta Grossa UEPG, Dept Clin & Toxicol Anal, Ponta Grossa, PR, Brazil-
dc.description.affiliationEAS, Ponta Grossa, PR, Brazil-
dc.description.affiliationUniv Estadual Paulista UNESP, Dept Fisioterapia, Presidente Prudente, SP, Brazil-
dc.description.affiliationParana State Univ Ponta Grossa UEPG, Dept Dent, Ponta Grossa, PR, Brazil-
dc.description.affiliationUnespUniv Estadual Paulista UNESP, Dept Fisioterapia, Presidente Prudente, SP, Brazil-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofMetabolism-clinical and Experimental-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.